Platforms

Inoviem provides breakthrough protein technologies for each phase of the drug development process.
One of the major advantages of our label-free technologies used under physiological conditions and in human tissue – NPOT® and PIMS® – is that the test compound retains its original structure, as well as the exact same molecular structure that would be used in therapy

NPOT®

Unlocking drug mechanism of action in native biological contexts

LIPS

Designed to measure drug-target interactions with high accuracy in native environments, including cultured cells and patient tissues.

PIMS®

Designed to study molecular interactions and predict therapeutic responses in biomedical research

Biomarkers discovery

Methodology for the proteomic profiling of human individuals in the context of translational evaluation of biomarkers and clinical development of new drug candidates.

Need Help